X3
Device Hips
PDI 07613327025743
General payments
$93,315
Research payments
$2,723,006
Through program year 2025, $93,315 in general payments and $2,723,006 in research payments were reported against X3 (Hips).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $14,996 | 61 |
| 2025 | Research | $570,329 | 11 |
| 2024 | General | $26,350 | 74 |
| 2024 | Research | $500,121 | 61 |
| 2023 | General | $9,313 | 121 |
| 2023 | Research | $496,759 | 54 |
| 2022 | General | $25,971 | 140 |
| 2022 | Research | $623,782 | 21 |
| 2021 | General | $16,685 | 172 |
| 2021 | Research | $532,015 | 17 |
Breakdown
The top 5 of 55 recipients; each share is of general payments naming this product in 2025.
The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 18 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
568 general · 164 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.